Manage Your Liver
Q:

Liver protection after hepatitis C treatment is the key to successful recovery

Liver protection after hepatitis C treatment is the key to successful recovery
A:

The launch of direct-acting antivirals (DAAs) in recent years has made a huge impact on the treatment of hepatitis C. Not only has this new option made viral clearance possible for many patients, it also has been proved to have higher success rate than traditional interferon treatment. Studies have shown that DAAs can produce a 90% sustained virologic response (SVR) rates for most HCV genotypes. [1] However, are these DAAs the perfect magic potion patients have been longing for?

 

There is no doubt of the effectiveness of DAAs however there are also shortcomings that cannot be neglected. First, these antiviral drugs were only designed to eradicate the virus; they do not help with the recovery of liver cells, nor can they reverse fibrosis or cirrhosis. Once the virus has been eradicated from the body, the cause of liver damage is removed, but what has been damaged remains damaged. Therefore, even after successful antiviral treatment, the patient must rely on the liver’s self-repair ability to regenerate new healthy liver cells, before normal liver function can resume.

 

Second, recent studies found that DAAs are associated with an increased risk of HCC recurrence. The two different studies indicate that patients infected with hepatitis C virus who received DAA therapy were more likely to experience a recurrence of hepatocellular carcinoma (HCC) or liver cancer than those who had no previous history of the disease. [1] One study pointed out that high recurrence rate of HCC can occur in hepatitis C patients taking these antiviral drugs, especially cirrhotic patients. [2] In another research, a “high rate” of HCC recurrence has also been found in patients who had received prior DAA therapy. [3]

 

In view of the above, the path to recovery and health must not stop at DAAs and eradication of the virus. Close monitoring and follow up is necessary for patients on DAA treatment and those who have achieved SVR, especially those with fibrosis or cirrhosis, as these are the most important risk factors for developing HCC. As mentioned previously, DAAs cannot help to treat fibrosis or cirrhosis. Thus, patients must rely on other methods for recovery and prevention of HCC.

 

One option is YHK, a natural liver therapy from Japan. It has been scientifically proven to help to regenerate healthy liver cells, repair damaged ones as well as prevent or halt cirrhosis. It contains anti-fibrotic properties which can protect and improve liver function. Clinical studies indicate that YHK is effective in reducing ALT and AST levels in patients, normalizing liver function and reversing early liver fibrosis and cirrhosis. [4] In addition, YHK has anti-tumor effects that help to prevent liver cancer. All these properties can help to decrease the risk of liver cancer and liver failure. [5]

 

To date, there is not a single product that can guarantee restoration of liver function and liver health. But with YHK, the shortcomings of DAAs can be compensated. Together, they provide an all-rounded treatment that cover virus clearance and long term protection. “If you don’t treat these patients and ameliorate their liver function, and if hepatocellular carcinoma occurs, you have no chance of curing them. But if you ameliorate liver function and they develop hepatocellular carcinoma, you can cure it better because their improved liver function will allow an ablation.” - Dr Brillanti, investigator of one of the studies. [1] The development of DAAs is no doubt one big step for hepatitis C patients toward health, but post treatment protection such as YHK is also important to ensure long-lasting liver health, especially for patients with cirrhosis.

 

Disclaimer:
  • * All research and clinical data should be used as reference purposes only, results may vary.
Related Questions
A:
Recently we have received quite a few enquiries about YHK’s effect on managing ALT level. Many are curious about YHK’s mechanism of normalising high ALT level as quickly as in 10 days. Some wonder if such fast result is safe, while some have doubts on how long the effective results can last. Therefore, we think it is a great opportunity to discuss how YHK helps with the problem of high ALT level.   What causes high ALT? In order
A:
As many of you may have known, reports of the new hepatitis C treatment being associated with a higher risk of liver cancer were found when the treatment came out. One of the most notable cases is the development of a 7 cm cancer tumour in just 6 months after the patient receiving the new treatment. Researchers have been investigating on this issue, and a
Hit Questions
A:
The liver carries out essential functions, including detoxifying harmful substances in your body, cleaning your blood and making new blood and other vital nutrients. Cirrhosis is scarring of the liver caused by long-term liver damage. The loss of liver cells turns into scar tissue which prevents the liver working normally, reducing or in some cases, completely losing liver function. Cirrhosis is a long-term chronic liver damage; it is often caused by chronic live
A:
ALT (Alanine Aminotransferase / SGPT) is a type of enzyme found in liver cells. When the liver cells are functioning normally, the ALT enzymes should be contained within the liver cells.    You can imagine each liver cells as a balloon, and the ALT enzymes are the air inside the balloon. When the balloon is damaged, the air will be released. And when the liver cells is damaged, ALT enzymes are released into the bloodstream, therefore we are able to find out the l
A:
ALT (Alanine Aminotransferase / SGPT) is an enzyme that is mainly found in liver cells. The level of ALT in our bloodstream is the primary indicator of liver health.   What does high ALT indicate? ALT enzymes are normally contained within liver cells when the liver is healthy, but when the liver cells are injured or damaged by whatever means, ALT enzymes are released into the bloodstream, causing levels to go up. Therefore, by measuring the
A:
Fibrosis is scarring of the liver that results from chronic inflammation. It is a process where the damaged, dying liver cells are replaced by fibrous scar tissue, causing the liver to become hard. The extent of liver fibrosis can vary, and it is often classified in several stages. The most common classification is a scale from F0 to F4. F0 indicates no fibrosis. A normal liver is at a stage between F0 and F1. F2 denotes light fibrosis, and F3 indicates severe fibrosis. When scar tissue build
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Have Questions?
Sumbit your question to us for profeessional answers!
Looking for help? Ask our customer support team!
Contact Us
Subscribe To Our Mailing List And
Never Miss Another Great Promotion!
Join our mailing list to receive latest new about our company, plus health articles. You will also be able to receive early bird discount from us!
Maybe Later, Thank you.
Subscribe success! You will receive latest new soon.